CD44+/CD117+ cells isolated from human ovarian tumors express high levels of TG2, and in vitro treatment of IGROV1 cells with TGF-β enhanced spheroid formation in culture and increased the number of CD44+/CD117+ cells. This evidence concerns the gene TGM2 and ovarian neoplasm.